Anticancer Drugs Durvalumab Oncology Pharmacology Physiotherapy

Durvalumab (Warnings-6)

In this article we will discuss Durvalumab (Warnings-6)

In this article, we will discuss Durvalumab (Warnings-6). So, let’s get started.

Immune-Mediated Pneumonitis

Durvalumab can cause immune-mediated pneumonitis. The incidence of pneumonitis is higher in patients
who have received prior thoracic radiation.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.